NCT06019195

Brief Summary

The central hypothesis of this study is that closer adherence to time restricted eating (TRE) will improve endothelial function, neurovascular (NVC) responses, resulting in improved cognitive performance, potentially through activation of SIRT1-dependent vasoprotective pathways.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 31, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

May 13, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 2, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2026

Completed
Last Updated

February 6, 2026

Status Verified

February 1, 2026

Enrollment Period

1.7 years

First QC Date

August 24, 2023

Last Update Submit

February 4, 2026

Conditions

Keywords

Intermittent FastingAging

Outcome Measures

Primary Outcomes (3)

  • Change in neurovascular coupling using functional near infrared spectroscopy (fNIRS)

    Functional near infrared spectroscopy (fNIRS) will be performed during the cognitive n-back task. fNIRS approach generates data that represent a relative change in oxygenated and deoxygenated hemoglobin measured over the cortical brain tissues. Neurovascular coupling will be evaluated as a change in oxy- and deoxy-hemoglobin between before and after completion of study.

    baseline, up to 6 months

  • Change in neurovascular coupling using the dynamic retinal vessel analysis

    Flicker light-induced dilation of the retinal vessels (percentage increase over baseline diameter) will be measured in the right or left eye of each study participant using the Dynamic Vessel Analyzer (DVA, IMEDOS Systems, Jena, Germany). The change in retinal vessel diameters is tracked and reported as a %change from baseline, before and after completion of study.

    baseline, up to 6 months

  • Change in EEG spectra

    EEG signal will be collected to generate spectral data. These data will be used for comparison of EEG activity between before and after treatment. Units of measure - power spectral density. Reported as a %change from baseline, before and after completion of study.

    baseline, up to 6 months

Secondary Outcomes (16)

  • Change in microvascular endothelial function

    baseline, up to 6 months

  • Change in arterial stiffness

    baseline, up to 6 months

  • Change in Glycocalyx - perfused boundary region

    baseline, up to 6 months

  • Change in capillary density

    baseline, up to 6 months

  • Change in red blood cell velocity

    baseline, up to 6 months

  • +11 more secondary outcomes

Study Arms (1)

Time restricted eating

EXPERIMENTAL

not more than 10 hrs. eating window daily goal for 6 months

Other: Time restricted eating

Interventions

not more than 10 hrs. eating window daily goal for 6 months

Also known as: intermittent fasting
Time restricted eating

Eligibility Criteria

Age55 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥55 and ≤80 years of age
  • Adequate hearing and visual acuity to participate in the examinations
  • Ability to read and write in English
  • Competence to provide informed consent.
  • Mini Montreal Cognitive Assessment ≥12
  • Mini Nutritional Assessment ≥12

You may not qualify if:

  • Vision or hearing impairment that would impair the ability to complete study assessments
  • Active CNS disease including multiple sclerosis, uncontrolled seizures, active brain cancer
  • Cerebrovascular accident other than TIA within 60 days prior to Visit 0
  • Major psychiatric disease, including major depression not currently controlled on medications, alcohol or drug abuse
  • Diabetics prescribed sulfonylureas, meglitinides, and insulin
  • Any other medical condition which, in the opinion of investigator, would render the patient inappropriate or too unstable to complete the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Translational GeroScience Laboratory

Oklahoma City, Oklahoma, 73117, United States

Location

Related Publications (2)

  • da C Pinaffi-Langley AC, Szarvas Z, Peterfi A, Kaposzta Z, Mukli P, Shahriari A, Muranyi M, Pinto CB, Owens CD, Adams C, Karfonta B, Rohan M, Tarantini S, Yabluchanskiy A. Time-restricted eating for prevention of age-related vascular cognitive decline in older adults: A protocol for a single-arm open-label interventional trial. PLoS One. 2024 Dec 9;19(12):e0314871. doi: 10.1371/journal.pone.0314871. eCollection 2024.

    PMID: 39652561BACKGROUND
  • da C Pinaffi-Langley AC, Pinto CB, Mukli P, Peterfi A, Kaposzta Z, Owens CD, Szarvas Z, Muranyi M, Adams C, Shahriari A, Balasubramanian P, Ungvari Z, Csiszar A, Conley S, Hord NG, Anderson L, Tarantini S, Yabluchanskiy A. Energy metabolism dysregulation, cerebrovascular aging, and time-restricted eating: Current evidence and proof-of-concept findings. PNAS Nexus. 2024 Nov 8;3(11):pgae505. doi: 10.1093/pnasnexus/pgae505. eCollection 2024 Nov.

    PMID: 39584020BACKGROUND

MeSH Terms

Conditions

Intermittent Fasting

Condition Hierarchy (Ancestors)

FastingFeeding BehaviorBehavior

Study Officials

  • Andriy Yabluchanskiy, MD, PhD

    University of Oklahoma

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2023

First Posted

August 31, 2023

Study Start

May 13, 2024

Primary Completion

February 2, 2026

Study Completion

February 2, 2026

Last Updated

February 6, 2026

Record last verified: 2026-02

Locations